Softwr

Healthcare · head to head

Kareo Clinical vs Woebot Health

Kareo Clinical logo

Kareo Clinical

Healthcare

Specialized EHR and practice management for independent and small practices

From
$89/month
Rated
-
Full reviewWebsite
Woebot Health logo

Woebot Health

Healthcare

Conversational CBT chatbot that withdrew from consumer distribution and now sells only to payers and providers

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Kareo Clinical kareo is now part of Tebra and sold under the Tebra brand rather than as a standalone product; Woebot Health the company withdrew its consumer app in June 2025 after concluding FDA marketing authorisation was not achievable at acceptable cost, which is a plain signal about both regulatory position and commercial durability.
  • They diverge on capability: Kareo Clinical covers Electronic Health Records, Woebot Health covers Scripted CBT dialogue.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Kareo Clinical and Woebot Health actually diverge.

Attributes where Kareo Clinical and Woebot Health differ
AttributeKareo ClinicalWoebot Health
Starting price$89/monthOn request
Pricing modelsubscriptionquote
PlatformsWeb, MobileiOS, Android, Web
Founded2010Unknown

Identical on both: free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Kareo Clinical

  • Electronic Health Records
  • Scheduling
  • Patient Portal
  • Medical Billing
  • ePrescribing
  • Analytics
  • Labs
  • Pharmacies

Only in Woebot Health

  • Scripted CBT dialogue
  • Mood tracking
  • Crisis routing
  • Between-session support
  • Payer deployment
  • Provider copilot positioning
  • Research licensing
  • Population reporting

What people use each for

The jobs each tool is most often brought in to do.

Kareo Clinical

  • Practice management, scheduling and billing for independent medical practicesnot Woebot Health
  • Electronic health records and e-prescribing for small clinicsnot Woebot Health
  • Insurance claim submission and patient payment collectionnot Woebot Health

Woebot Health

  • A health plan wanting a low intensity behavioural health option for members on a waiting list for therapynot Kareo Clinical
  • A provider organisation offering structured between-session CBT practice to patients already in treatmentnot Kareo Clinical
  • A research group running a trial that needs a clinically scripted rather than generative conversational agent for safety reasonsnot Kareo Clinical
  • A payer targeting a specific population such as postpartum members where scripted CBT content already existsnot Kareo Clinical

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Kareo Clinical

  • Kareo is now part of Tebra and sold under the Tebra brand rather than as a standalone product
  • Tebra publishes no rate: pricing varies with provider count, features and implementation requirements and is quoted during a demo
  • Billing counts clinical providers such as MDs, DOs, NPs and PAs, so adding a prescriber raises the bill even though non clinical staff are free
  • Electronic prescribing of controlled substances setup costs about $75 per provider as a one time fee
  • PDMP integration costs $500 one time per facility plus about $50 per user per year

Woebot Health

  • The company withdrew its consumer app in June 2025 after concluding FDA marketing authorisation was not achievable at acceptable cost, which is a plain signal about both regulatory position and commercial durability.
  • It is not an FDA cleared treatment for any indication, so it cannot be positioned to members as therapy and cannot substitute for a covered behavioural health benefit.
  • The scripted, non-generative design that makes it safe also makes it feel rigid next to current conversational AI, and engagement drops off quickly once users hit the edges of the script.
  • Published evidence is short-horizon symptom change in selected populations, mostly young adults, with little evidence of durable benefit or effect at whole-population scale.
  • With consumer distribution gone, the remaining business depends on a small number of payer and provider contracts, so a buyer should assume real vendor continuity risk over a multi-year term.

Pricing, plan by plan

Kareo Clinical

$89/month
  • Clinical Starter$89/month
    • EHR
    • Scheduling
    • Patient Portal
  • Clinical Plus$189/month
    • Everything in Starter
    • Billing
    • Analytics

Woebot Health

On request
  • Woebot for payers and providers$undefined/year
    • Contracted per member per month or as a population licence
    • Sold to health plans and provider organisations, not to employers or individuals
    • No consumer purchase route since the app closed in June 2025

Which should you pick?

Choose Kareo Clinical if

  • You need electronic health records.
  • You work on Web, Mobile.
  • You also want scheduling.
Kareo Clinical review

Choose Woebot Health if

  • You need scripted cbt dialogue.
  • You work on iOS, Android, Web.
  • You also want mood tracking.
Woebot Health review

Questions people ask

Is Kareo Clinical or Woebot Health better?
Neither clearly leads. Kareo Clinical starts at $89/month and Woebot Health at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Kareo Clinical or Woebot Health?
Kareo Clinical starts at $89/month and Woebot Health at On request.
Does Kareo Clinical or Woebot Health run on more platforms?
Kareo Clinical runs on Web, Mobile. Woebot Health runs on iOS, Android, Web.
What is Kareo Clinical best used for?
Kareo Clinical is most often used for practice management, scheduling and billing for independent medical practices, electronic health records and e-prescribing for small clinics, insurance claim submission and patient payment collection. Of those, practice management, scheduling and billing for independent medical practices and electronic health records and e-prescribing for small clinics are not what Woebot Health is typically brought in for.
What can Kareo Clinical do that Woebot Health cannot?
Kareo Clinical covers Electronic Health Records, Scheduling, Patient Portal, Medical Billing. Woebot Health covers Scripted CBT dialogue, Mood tracking, Crisis routing, Between-session support.

Answered from the vendors’ own pages

Kareo Clinical: How much does Kareo Clinical (now Tebra) cost?

Kareo Clinical pricing is not published publicly. Pricing is based on the number of clinical providers in your practice, not seat licenses. Setup includes optional EPCS at $75/provider and PDMP Integration at $500 one-time per facility plus $50/user/year.

Source
Woebot Health: Is Woebot still available?

Not to consumers. The consumer app closed in June 2025. The company continues to offer the product to payers, providers and researchers.

Kareo Clinical: Does Tebra charge for front desk staff and medical assistants?

No. Tebra provides unlimited non-clinical staff access at no extra cost. Front desk staff, medical assistants, billers, and office admins can all access scheduling, charting, and claims modules without increasing billing.

Source
Woebot Health: Is it FDA cleared?

No. It held Breakthrough Device designation but never obtained marketing authorisation, and the founder cited the cost of that pathway as the reason for closing the consumer app.

Kareo Clinical: Are there reduced rates for low-volume practices on Tebra?

Yes. Practices with providers billing under 100 claims monthly receive lower-tier pricing for those low-volume providers.

Source
Woebot Health: Is it generative AI?

Historically no. The dialogue is clinician-written and rule-based, a deliberate safety choice that limits how naturally it converses.

Woebot Health: What does the evidence show?

Randomised studies reported reduced depressive symptoms over short periods in selected populations, notably young adults. That is symptom change in a trial, not demonstrated population outcomes.

Share

Related pages

More on Kareo Clinical

More on Woebot Health

Keep looking

Other head to heads